ALK gene mutations are significant drivers in the development of NSCLC, though they occur in only about 2%–7% of cases, often as echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusions [1, 2]. Here, EML4 is linked to non-small cell lung carcinoma.